Switching to biphasic insulin aspart 30/50/70 from biphasic human insulin 30/50 in patients with type 2 diabetes in normal clinical practice: observational study results.
- Nobels, Frank
- D'Hooge, Dirk
- Crenier, Laurent
Publication date
June 2012
DOI Publisher
Informa Healthcare ISSN
0300-7995 Citation count (estimate)
3Abstract
To investigate the safety and efficacy of switching to biphasic insulin aspart (BIAsp) 30, 50 or 70 in patients with type 2 diabetes previously treated with biphasic human insulin (BHI) 30/50 (with or without oral glucose-lowering drugs) in routine clinical practice.Evaluation StudiesJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tSCOPUS: ar.jinfo:eu-repo/semantics/publishe
Add to ORKG